03681 SINOMAB BIO-B
- 1.000
- 0.0000.00%
SINOMAB BIO-B News
Have Insiders Sold SinoMab BioScience Shares Recently?
SinoMab BioScience's H1 Loss Narrows as Revenue Rises; Shares Fall 15%
Express News | SinoMab BioScience - Hy Revenue RMB2 Mln Vs RMB1.4 Mln
Express News | SinoMab BioScience Ltd - Hy Loss RMB90.6 Mln
Sinomab Bioscience Administers First Dose of Atopic Dermatitis Drug
SinoMab Doses First Patient in Clinical Study of Atopic Dermatitis Drug in China
SinoMab BioScience Raises HK$62.2 Million From Thirteen Share Subscriptions
SinoMab BioScience Issues 56.8 Million Shares to 15 Investors
SinoMab Doses First Batch of Subjects in Phase 1 Trial of Atopic Dermatitis Drug in China
China Accepts Clinical Trial Application for SinoMab BioScience's Alzheimer's Treatment; Shares Rise 3%
China Accepts New Drug Application of SinoMab's Dermatitis Medication; Shares Rise 3%
China Accepts SinoMab's Biologics License Application for Arthritis Treatment
SinoMab Bioscience to Shrink Loss in H1
SinoMab Bioscience Obtains Clinical Trial Approval in China for Asthma Drug
SinoMab Bioscience Achieves Primary Endpoints for Phase III Clinical Study of Rheumatoid Arthritis Treatment; Shares Cimb 4%
SinoMab BioScience Completes Issuance of More Than 28 Million Shares
SinoMab BioScience Targets $6.5 Million in Share Subscription Deal
Express News | SinoMab BioScience Proposes New Share Option Scheme
Biden Signs Order to Curb China in Biotechnology Following Chip Bill
SinoMab BioScience Enlists Subjects for US Phase 1 Trial of Anti-Asthma Drug
No Data
